Target intelligence / Profile preview

Raftlin, lipid raft linker 1 (RFTN1)

Target
RFTN1
Molecular classification
Other (membrane-associated scaffold protein), Lipid raft-associated protein
01

Overview

Raftlin, lipid raft linker 1 (RFTN1) is a membrane-associated scaffold protein predominantly found in immune cells, especially B and T lymphocytes. It plays a key role in the formation and stability of lipid rafts—cholesterol-rich membrane microdomains that serve as platforms for cell signaling. In B cells, Raftlin is critical for the proper assembly of lipid rafts, which in turn regulate antigen-dependent B-cell receptor (BCR) signaling and cell proliferation. Its localization is determined by N-terminal acylation (myristoylation and palmitoylation). Raftlin participates in the trafficking and internalization of Toll-like receptors and double-stranded RNA, thereby linking membrane microdomains to innate immune signaling. Genetic association studies have implicated it as a biomarker for glaucoma, with other studies noting its association with some hereditary red blood cell disorders and chronic otitis media. No drugs are known to interact directly with Raftlin, and it is not considered a classical drug target such as an enzyme, receptor, or transporter.

Other names
RaftlinRFTN1
02

Biological functions

Lipid raft assembly and maintenanceB-cell receptor (BCR) signaling pathwayPositive regulation of cell growth rateDouble-stranded RNA bindingToll-like receptor 3 (TLR3) signaling mediationT-cell receptor signaling (regulation of tyrosine kinase localization)
03

Disease associations

Glaucoma (biomarker role)Genetic variants associated with spherocytosis type 3 and chronic purulent otitis mediaPotential involvement in immune response regulation (no direct established role in cancer, inflammation, or other major disease classes as a primary target)
04

Biomarkers

Glaucoma (identified as a biomarker by genome resources)

Beyond the preview

Go deeper on Raftlin, lipid raft linker 1 (RFTN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raftlin, lipid raft linker 1 (RFTN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call